HCN4 and angina pectoris: This ‘pacemaker depolarization’ phase is known to be slowed by loss-of-function mutations in the HCN4 that lead to lower heart rate31 and the If is the known site of action for ivabradine and other therapeutic agents used to slow heart rate in angina patients32.